We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News
Medica 2026
AI Critical Care Surgical Techniques Patient Care Medical Imaging Health IT Point of Care Business Focus

Parker Laboratories Introduces Groundbreaking Ultrasound Innovations

By HospiMedica International staff writers
Posted on 13 Nov 2023
Image: Tristel ULT is a high-level disinfectant foam to disinfect cleaned, reusable, non-lumened ultrasound probes (Photo courtesy of Parker Labs)
Image: Tristel ULT is a high-level disinfectant foam to disinfect cleaned, reusable, non-lumened ultrasound probes (Photo courtesy of Parker Labs)

Parker Laboratories Inc. (Fairfield, NJ, USA) is introducing innovative ultrasound products at MEDICA 2023 that are designed to increase patient safety, lower costs, and improve workflow in busy healthcare settings that rely on point-of-care ultrasound. The company is introducing the UltraDrape II UGPIV Barrier and Securement Dressing and Tristel ULT high-level disinfectant foam that promotes patient safety while reducing costs and increasing efficiency for ultrasound-guided percutaneous procedures.

Ultrasound technologies offer important advantages for vascular access procedures such as inserting central lines and peripheral catheters, improving outcomes while also reducing risks and healthcare costs. Hospitals are seeing an increase in the number of patients with difficult vascular access (DiVA) who require ultrasound guidance to achieve peripheral vascular access. UltraDrape II is the next generation of Parker’s groundbreaking UltraDrape, the only dressing designed specifically for use during UGPIV procedures. Like the original, UltraDrape II is a sterile, dual-action barrier and securement dressing that provides a “gel-free” insertion site to decrease the risk of contamination and securement failure both during and after UGPIV procedures.

Tristel ULT is a high-level disinfectant that uses unique, proprietary foam containing chlorine dioxide for reprocessing ultrasound probes. It was recently granted FDA clearance for use as a high-level disinfectant for ultrasound probes used within body cavities and for skin-surface transducers, making it the first product of its kind to be available in the United States. Tristel ULT is the only high-level disinfectant foam that can be safely used on ultrasound probes, and it has been shown to be effective against pathogens ranging from SARS-CoV-2 to Mycobacterium tuberculosis. As a rapid and inexpensive high-level disinfectant, Tristel ULT represents an important advance offering several advantages over other methods of high-level disinfection currently on the market.

“As the use of ultrasound guidance for vascular access procedures increases, so does the need for supplies that make these procedures safer and more efficient, without increasing costs,” said Neal Buchalter, president of Parker Laboratories. “These new products are just a few of the innovative and cost-effective solutions we are committed to bring to market to increase patient safety and improve workflow for busy vascular access clinicians.”

Related Links:
Parker Laboratories Inc.

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Medical Examination & Procedure Light
Vega 80
Rapid Sepsis Test
SeptiCyte RAPID

Channels

Artificial Intelligence

view channel
Image: Design-science framework integrating CML and LLM pipelines for supply chain risk evaluation. (Gupta I, Konduru H, Correa S, et al. A causal analytics approach for interpretable supply chain risk and supplier performance evaluation. Supply Chain Analytics, 2026. doi:10.1016/j.sca.2026.100248)

Causal AI Tool Withholds Ovarian Cancer Treatment Recommendations When Evidence Insufficient

Ovarian cancer treatment often requires individualized decisions, particularly when available patient data do not clearly favor one therapeutic approach. However, artificial intelligence (AI) systems may... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: Overview of the study design, including participant recruitment, multimodal neuroimaging analysis, stage- and cognition-informed feature selection, and development and validation of the DBFG-Net model. CKD-CI, CKD with cognitive impairment; CKD-NCI, CKD without cognitive impairment; HCs, healthy controls; CBF, cerebral blood flow; DBFG-Net, Dual-Branch Feature-Gated Network. (Photo courtesy of Wenbo Yang and Lijun Song, Capital Medical University)

AI Combines Brain Imaging Features to Identify Cognitive Impairment in CKD

Chronic kidney disease (CKD) can affect multiple organs, including the brain, with cognitive impairment emerging as a common complication. Changes in executive function, attention, and memory can reduce... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Medica 2023